First Citizens BancShares, Inc. (FCNCA) Market Cap & Valuation Ratios

First Citizens BancShares, Inc. (FCNCA) has a market cap of $26.8B, a trailing P/E of 12.7 and a price-to-sales ratio of 2.8, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

FCNCAFirst Citizens BancShares, Inc.Follow FCNCA — free

Banks - Regional · Financials

—

Price chart with a free account

Market cap: 26.8B
P/E TTM: 12.7
Dividend yield: 0.3%
52-week: —
Next earnings: 21 Jan, in 89 days

Peers

banks - regional · nearest by market cap · trailing 12 months

Company	Mkt cap, $B	P/E	P/B	ROE	Div. yield	Rev. growth
FCNCA	27	12.7	1.23	11%	0.3%	+0.9%
TFC	59	11.1	0.92	9%	4.3%	+4%
FITB	48	22.1	1.39	8%	3.0%	+24%
MTB	32	11.7	1.15	11%	2.7%	+6%
HBAN	32	14.4	0.97	9%	3.9%	+26%
CFG	27	14.2	1.05	8%	2.8%	+11%
RF	24	11.6	1.29	12%	3.7%	+4%
KEY	22	12.3	1.14	10%	3.9%	+52%
EWBC	18	12.6	1.94	17%	2.1%	+14%
PNFP	15	19.4	1.02	8%	1.2%	+18%
MFG	12	—	—	11%	—	+38%
Median of these 10		12.6	1.14	10%	3.0%	+16%

P/E 12.7 vs. a peer median of 12.6; P/B 1.23 vs. 1.14. FCNCA's own P/E sits at the 79th percentile of its history.

Growth vs. price

each dot a company · hover or tap for values

MFG has no P/E (earnings not positive) and is left out · hover or tap a dot for values.

First Citizens BancShares, Inc. — questions

What is First Citizens BancShares, Inc.'s market cap?: $26.8B.
What is First Citizens BancShares, Inc.'s P/E ratio?: 12.7 on trailing twelve-month earnings to 2026-06-30.
What is First Citizens BancShares, Inc.'s price-to-sales ratio?: 2.8.

Every figure on this page comes from First Citizens BancShares, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.